menu close
www.sionnatx.com

Sionna Stock

Company Profile:

Sionna is a clinical-stage biopharmaceutical company focused on transforming cystic fibrosis treatment by developing novel medicines that normalize the function of the CFTR protein. Their approach centers on stabilizing the nucleotide-binding domain 1 (NBD1) of CFTR to correct defects caused by the F508del mutation, aiming to restore CFTR function and improve patient outcomes.

Sign up for SecondMarket® to view the market and buy or sell Sionna Stock
Buy + Sell
  • Headquarters: Waltham, MA
  • Year Founded: 2020
  • Sector: Health Care
Leverage Your Equity to Help Achieve More.

Sionna Management Team

  • Board Member

    Peter Thompson

  • President, CEO, Board Member

    Mike Cloonan

  • Board Member

    Josh Resnick

  • Board Member

    Marcella Kuhlman Ruddy

  • Co-Founder

    Mark Munson

  • Board Member

    Paul Clancy

  • CFO

    Elena Ridloff

  • Co-Founder

    Greg Hurlbut

  • Board Member

    Laurie Stelzer

  • Board Member

    Bruce Booth

  • Chief Medical Officer

    Charlotte McKee

  • Board Member

    Lucian Iancovici

  • Chief People Officer

    Vanya Sagar

  • Board Member

    Jo Viney

  • Board Member

    Edd Fleming

Learn More About Sionna Stock

Buy Sionna Stock
01

Sionna stock does not trade on public stock exchanges. Sionna stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Sionna stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Sionna Stock
02

Sionna Stock does not trade on public stock exchanges. In order to sell Sionna shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Sionna Stock Price
03

Sionna does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Sionna share price and other valuable private market data.

Read more about secondary market private company stock prices:

Sionna Stock Ticker Symbol
04

There is no ticker symbol for Sionna stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Sionna Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Sionna stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Sionna Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Sionna stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Sionna Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Sionna IPO
08

Sionna is a private company and has not had an IPO. There is currently no Sionna IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Sionna IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Sionna Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Cityblock Health-Logo

Cityblock Health

Tech-driven care provider for communities with complex needs.

Benchling-Logo

Benchling

Cloud based platform for research and development in biotechnology.

Insitro-Logo

insitro

Drug discovery and development company.

Lyra Healthcare-Logo

Lyra

Digital health startup using technology to connect companies and employees to mental health providers.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Tonal Strong-Logo

Tonal

Developed a fitness system, called Tonal, that combines revolutionary equipment, expert-led videos, and personalized guidance into full body workouts users can do on demand from the convenience of home.

Somatus-Logo

Somatus

Integrated care for patients with or at risk of developing kidney disease.

Devoted

Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Source: Nasdaq Private Market Tape D®